No registrations found.
ID
Source
Brief title
Health condition
VIM-positive Pseudomonas aeruginosa carriage
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study endpoint is finding positive body sites of VIM-positive P. aeruginosa, other than the standard surveillance culture sites.
Secondary outcome
Secondary endpoints are patient characteristics favouring specific body sites being colonized by VIM-positive Pseudomonas aeruginosa.
Background summary
Currently, throat and rectum samples are the standard body sites for surveillance cultures to identify patients with Verona Integron-encoded Metallo-β-lactamase (VIM)-positive Pseudomonas aeruginosa (VIM-PA). Pseudomonas aeruginosa in general favours moist areas. Therefore, it is likely that VIM-PA has the ability to colonize other body sites as well. It is unknown, however, to which extent patients are also culture positive at other body sites, for example the navel, the ears, or between the toes. Inclusion of additional body sites may increase the detection rate.
Study objective
VIM-positive Pseudomonas aeruginosa can be found in other body sites besides throat and rectum, which are currently used as the standard surveillance culture sites.
Study design
1
Inclusion criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria: All living patients aged >18 years old, known to be carrying VIM-PA or formerly carrying VIM-PA, with a signed consent sheet.
Exclusion criteria
A potential subject who meets any of the following criteria will be excluded from participation in this study: no informed consent.
Design
Recruitment
IPD sharing statement
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL9674 |
| Other | METC Erasmus MC : MEC-2021-0525 |